Demonstration of the one-year pain and functional outcomes, including sit to stand.
Academic tertiary care medical center.
Forty-eight consecutive patients with refractory trochanteric pain due to iliotibial band (ITB) tendinopathy. Fifty-six hips were treated; 8 patients underwent bilateral procedures. Electronic medical record review of consecutive patients who underwent ITB TENEX® was performed at Montefiore Medical Center from December 2019 to December 2021. Institutional guidelines recommended TENEX® for greater trochanteric pain refractory to conservative treatment and ultrasound (US) confirmed ITB tendinopathy (hypoechogenicity or thickened tendon > 6 mm). Pain level, as well as sit-to-stand, side-lying, and walking tolerance levels were evaluated at baseline preprocedure visit and one-year visit. Follow-up was performed by independent practitioners and corroborated by chart review.
Numeric Rating Scale (NRS-11) improved by 4 points across all patients. Seventy percent of patients endorsed pain relief at one-year visit. Median preprocedure NRS-11 was 9. The reported median NRS-11at one year was 5 (Wilcoxon signed rank NRS-11 demonstrated a Z score of -6.042 with P < 0.001). One-year analysis among all patients revealed 57%, 78%, and 66% improvement in side-lying, sit-to-stand, and walking tolerance levels, respectively.
We believe that our results must be confirmed with a randomized control trial with a control arm and more patients included.
PUT of the ITB using the TENEX® tissue remodeling device could be a safe and effective treatment for ITB tendinopathy-associated GTPS.
显示一年的疼痛和功能结果,包括坐着站着。
学术三级护理医疗中心。
48例连续患者因髂胫带(ITB)肌腱病引起的难治性股骨粗隆痛。56髋接受了治疗;8例患者接受了双侧手术。2019年12月至2021年12月,在蒙特菲奥雷医疗中心对接受ITBTENEX®治疗的连续患者进行了电子病历审查。机构指南建议TENEX®用于保守治疗难以治疗的大转子疼痛,超声(US)证实ITB肌腱病(回声减退或肌腱增厚>6mm)。疼痛程度,以及坐着站着,侧卧,在基线术前访视和1年访视时评估行走耐受水平.随访由独立从业人员进行,并通过图表审查证实。
数字评定量表(NRS-11)在所有患者中提高了4分。70%的患者在一年的访问中认可疼痛缓解。术前NRS-11中位数为9。一年报告的NRS-11中位数为5(Wilcoxon签名等级NRS-11显示Z评分为-6.042,P<0.001)。在所有患者中进行的为期一年的分析显示57%,78%,侧卧改善66%,坐到站,和行走耐受水平,分别。
我们认为,我们的结果必须通过一项具有对照臂的随机对照试验得到证实,并包括更多的患者。
使用TENEX®组织重塑装置对ITB进行PUT可以安全有效地治疗与ITB肌腱病相关的GTP。